

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | skeletal muscle adaptation (GO:0043501) | 9.80189806 |
| 2 | plasma membrane repair (GO:0001778) | 8.09239981 |
| 3 | actin filament-based movement (GO:0030048) | 8.06922233 |
| 4 | * skeletal muscle fiber development (GO:0048741) | 7.38596468 |
| 5 | response to stimulus involved in regulation of muscle adaptation (GO:0014874) | 7.03545720 |
| 6 | positive regulation of ryanodine-sensitive calcium-release channel activity (GO:0060316) | 6.92742768 |
| 7 | sarcomere organization (GO:0045214) | 6.62828473 |
| 8 | response to inactivity (GO:0014854) | 6.43989992 |
| 9 | * striated muscle contraction (GO:0006941) | 6.42956465 |
| 10 | striated muscle atrophy (GO:0014891) | 6.41293239 |
| 11 | glycogen catabolic process (GO:0005980) | 6.39328397 |
| 12 | skeletal muscle tissue regeneration (GO:0043403) | 6.36211521 |
| 13 | * myotube cell development (GO:0014904) | 6.22514124 |
| 14 | creatine metabolic process (GO:0006600) | 6.18501088 |
| 15 | purine nucleotide salvage (GO:0032261) | 6.02127035 |
| 16 | glucan catabolic process (GO:0009251) | 5.98531970 |
| 17 | response to muscle activity (GO:0014850) | 5.93214049 |
| 18 | pyrimidine ribonucleoside catabolic process (GO:0046133) | 5.93127481 |
| 19 | regulation of ryanodine-sensitive calcium-release channel activity (GO:0060314) | 5.78827309 |
| 20 | myofibril assembly (GO:0030239) | 5.78130993 |
| 21 | carnitine shuttle (GO:0006853) | 5.70952651 |
| 22 | * muscle contraction (GO:0006936) | 5.62210086 |
| 23 | cellular polysaccharide catabolic process (GO:0044247) | 5.57311404 |
| 24 | muscle atrophy (GO:0014889) | 5.56849720 |
| 25 | striated muscle adaptation (GO:0014888) | 5.51898552 |
| 26 | regulation of release of sequestered calcium ion into cytosol by sarcoplasmic reticulum (GO:0010880) | 5.49273288 |
| 27 | regulation of cell communication by electrical coupling (GO:0010649) | 5.44909580 |
| 28 | cytidine deamination (GO:0009972) | 5.44766699 |
| 29 | cytidine metabolic process (GO:0046087) | 5.44766699 |
| 30 | cytidine catabolic process (GO:0006216) | 5.44766699 |
| 31 | polysaccharide catabolic process (GO:0000272) | 5.28943452 |
| 32 | IMP metabolic process (GO:0046040) | 5.04405959 |
| 33 | * muscle system process (GO:0003012) | 5.00920198 |
| 34 | glycogen biosynthetic process (GO:0005978) | 4.98881269 |
| 35 | glucan biosynthetic process (GO:0009250) | 4.98881269 |
| 36 | fatty acid transmembrane transport (GO:1902001) | 4.78940784 |
| 37 | actomyosin structure organization (GO:0031032) | 4.71022249 |
| 38 | negative regulation of potassium ion transmembrane transporter activity (GO:1901017) | 4.66822460 |
| 39 | * muscle fiber development (GO:0048747) | 4.57720437 |
| 40 | regulation of acetyl-CoA biosynthetic process from pyruvate (GO:0010510) | 4.57468258 |
| 41 | fructose metabolic process (GO:0006000) | 4.51048569 |
| 42 | NADH metabolic process (GO:0006734) | 4.50040953 |
| 43 | muscle adaptation (GO:0043500) | 4.46651497 |
| 44 | positive regulation of mitochondrial calcium ion concentration (GO:0051561) | 4.46471465 |
| 45 | regulation of actin filament-based movement (GO:1903115) | 4.43687129 |
| 46 | cardiac muscle hypertrophy (GO:0003300) | 4.39547224 |
| 47 | glycogen metabolic process (GO:0005977) | 4.33235811 |
| 48 | positive regulation of myotube differentiation (GO:0010831) | 4.32416606 |
| 49 | regulation of skeletal muscle cell differentiation (GO:2001014) | 4.31911334 |
| 50 | glucan metabolic process (GO:0044042) | 4.24531407 |
| 51 | cellular glucan metabolic process (GO:0006073) | 4.24531407 |
| 52 | muscle cell cellular homeostasis (GO:0046716) | 4.23706241 |
| 53 | carnitine transmembrane transport (GO:1902603) | 4.21498802 |
| 54 | striated muscle hypertrophy (GO:0014897) | 4.18702832 |
| 55 | muscle organ development (GO:0007517) | 4.18693332 |
| 56 | myotube differentiation (GO:0014902) | 4.17265301 |
| 57 | regulation of acyl-CoA biosynthetic process (GO:0050812) | 4.15279886 |
| 58 | neuronal action potential propagation (GO:0019227) | 4.13951001 |
| 59 | muscle structure development (GO:0061061) | 4.11997722 |
| 60 | negative regulation of endoplasmic reticulum calcium ion concentration (GO:0032471) | 4.06086628 |
| 61 | skeletal muscle tissue development (GO:0007519) | 4.03645455 |
| 62 | muscle organ morphogenesis (GO:0048644) | 4.00568328 |
| 63 | response to activity (GO:0014823) | 3.99894853 |
| 64 | 2-oxoglutarate metabolic process (GO:0006103) | 3.93218925 |
| 65 | IMP biosynthetic process (GO:0006188) | 3.92099006 |
| 66 | muscle cell fate commitment (GO:0042693) | 3.90070884 |
| 67 | myoblast fusion (GO:0007520) | 3.89498311 |
| 68 | regulation of ventricular cardiac muscle cell membrane repolarization (GO:0060307) | 3.86881008 |
| 69 | amino-acid betaine transport (GO:0015838) | 3.83897943 |
| 70 | carnitine transport (GO:0015879) | 3.83897943 |
| 71 | gluconeogenesis (GO:0006094) | 3.82955285 |
| 72 | muscle hypertrophy (GO:0014896) | 3.82819191 |
| 73 | cardiac muscle contraction (GO:0060048) | 3.80856366 |
| 74 | regulation of coenzyme metabolic process (GO:0051196) | 3.76738365 |
| 75 | regulation of cofactor metabolic process (GO:0051193) | 3.76738365 |
| 76 | positive regulation of myoblast differentiation (GO:0045663) | 3.74710942 |
| 77 | negative regulation of skeletal muscle tissue development (GO:0048642) | 3.73611755 |
| 78 | negative regulation of muscle hypertrophy (GO:0014741) | 3.67988984 |
| 79 | regulation of relaxation of muscle (GO:1901077) | 3.67261162 |
| 80 | regulation of myotube differentiation (GO:0010830) | 3.66225324 |
| 81 | AMP metabolic process (GO:0046033) | 3.64605979 |
| 82 | muscle tissue morphogenesis (GO:0060415) | 3.64197077 |
| 83 | negative regulation of potassium ion transmembrane transport (GO:1901380) | 3.59658493 |
| 84 | syncytium formation (GO:0006949) | 3.53315411 |
| 85 | negative regulation of muscle contraction (GO:0045932) | 3.52694587 |
| 86 | cellular response to dexamethasone stimulus (GO:0071549) | 3.52467313 |
| 87 | striated muscle tissue development (GO:0014706) | 3.51546638 |
| 88 | syncytium formation by plasma membrane fusion (GO:0000768) | 3.50546213 |
| 89 | cellular carbohydrate catabolic process (GO:0044275) | 3.50432472 |
| 90 | adult heart development (GO:0007512) | 3.47224703 |
| 91 | hexose biosynthetic process (GO:0019319) | 3.46071424 |
| 92 | regulation of calcium ion transmembrane transporter activity (GO:1901019) | 3.45888403 |
| 93 | regulation of calcium ion transmembrane transport (GO:1903169) | 3.45888403 |
| 94 | regulation of calcineurin-NFAT signaling cascade (GO:0070884) | 3.42501499 |
| 95 | * striated muscle cell development (GO:0055002) | 3.42448894 |
| 96 | neuromuscular junction development (GO:0007528) | 3.40016299 |
| 97 | tricarboxylic acid cycle (GO:0006099) | 3.38733919 |
| 98 | regulation of skeletal muscle fiber development (GO:0048742) | 3.38303109 |
| 99 | cardiac muscle tissue morphogenesis (GO:0055008) | 3.36802694 |
| 100 | regulation of myoblast differentiation (GO:0045661) | 3.34120493 |
| 101 | negative regulation of calcium ion transmembrane transport (GO:1903170) | 3.31398696 |
| 102 | negative regulation of calcium ion transmembrane transporter activity (GO:1901020) | 3.31398696 |
| 103 | cardiac muscle hypertrophy in response to stress (GO:0014898) | 3.30864351 |
| 104 | muscle hypertrophy in response to stress (GO:0003299) | 3.30864351 |
| 105 | cardiac muscle adaptation (GO:0014887) | 3.30864351 |
| 106 | response to dexamethasone (GO:0071548) | 3.29253746 |
| 107 | regulation of striated muscle contraction (GO:0006942) | 3.23674545 |
| 108 | cardiac muscle cell development (GO:0055013) | 3.18708526 |
| 109 | negative regulation of ryanodine-sensitive calcium-release channel activity (GO:0060315) | 3.17782239 |
| 110 | negative regulation of necroptotic process (GO:0060546) | 3.16737151 |
| 111 | regulation of cardiac muscle contraction by regulation of the release of sequestered calcium ion (GO | 3.15573478 |
| 112 | cardiac myofibril assembly (GO:0055003) | 3.15455725 |
| 113 | skeletal muscle cell differentiation (GO:0035914) | 3.15311822 |
| 114 | positive regulation of calcium ion transmembrane transporter activity (GO:1901021) | 3.14579369 |
| 115 | * muscle cell development (GO:0055001) | 3.12309637 |
| 116 | regulation of cardiac muscle contraction by calcium ion signaling (GO:0010882) | 3.10650567 |
| 117 | negative regulation of cAMP-mediated signaling (GO:0043951) | 3.08904371 |
| 118 | regulation of sulfur metabolic process (GO:0042762) | 3.04970112 |
| 119 | cellular polysaccharide metabolic process (GO:0044264) | 3.03270899 |
| 120 | heart contraction (GO:0060047) | 2.97986536 |
| 121 | heart process (GO:0003015) | 2.97986536 |
| 122 | cellular polysaccharide biosynthetic process (GO:0033692) | 2.95803558 |
| 123 | muscle filament sliding (GO:0030049) | 13.1135077 |
| 124 | actin-myosin filament sliding (GO:0033275) | 13.1135077 |
| 125 | regulation of skeletal muscle contraction (GO:0014819) | 12.2862074 |
| 126 | * skeletal muscle contraction (GO:0003009) | 10.7278154 |
| 127 | actin-mediated cell contraction (GO:0070252) | 10.7240668 |
| 128 | sarcoplasmic reticulum calcium ion transport (GO:0070296) | 10.4280501 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | BP1_19119308_ChIP-ChIP_Hs578T_Human | 8.41718165 |
| 2 | PPARG_19300518_ChIP-PET_3T3-L1_Mouse | 3.90573438 |
| 3 | ESR1_20079471_ChIP-ChIP_T-47D_Human | 3.66833588 |
| 4 | TAF7L_23326641_ChIP-Seq_C3H10T1-2_Mouse | 3.12519055 |
| 5 | TAL1_26923725_Chip-Seq_MACROPHAGESS_Mouse | 3.10386042 |
| 6 | RARG_19884340_ChIP-ChIP_MEFs_Mouse | 2.59495891 |
| 7 | ESRRB_18555785_ChIP-Seq_MESCs_Mouse | 2.58081314 |
| 8 | TBX20_22080862_ChIP-Seq_HEART_Mouse | 2.48129768 |
| 9 | TBX20_22328084_ChIP-Seq_HEART_Mouse | 2.48129768 |
| 10 | RUNX1_26923725_Chip-Seq_MACROPHAGESS_Mouse | 2.46215350 |
| 11 | BCL3_23251550_ChIP-Seq_MUSCLE_Mouse | 2.35241578 |
| 12 | PRDM16_22522345_ChIP-ChIP_PALATE_MESENCHYMAL_Mouse | 2.28135160 |
| 13 | THRA_23701648_ChIP-Seq_CEREBELLUM_Mouse | 2.19282253 |
| 14 | ZNF263_19887448_ChIP-Seq_K562_Human | 2.17828318 |
| 15 | CDX2_19796622_ChIP-Seq_MESCs_Mouse | 2.08464442 |
| 16 | ZNF652_21678463_ChIP-ChIP_ZR75-1_Human | 1.96542117 |
| 17 | MEF2A_21415370_ChIP-Seq_HL-1_Mouse | 1.91871873 |
| 18 | CTCF_21964334_ChIP-Seq_BJAB-B_Human | 1.91304727 |
| 19 | ESR1_21235772_ChIP-Seq_MCF-7_Human | 1.77729116 |
| 20 | AR_21572438_ChIP-Seq_LNCaP_Human | 1.68853915 |
| 21 | CTCF_27219007_Chip-Seq_Bcells_Human | 1.68275987 |
| 22 | CREB1_26743006_Chip-Seq_LNCaP-abl_Human | 1.64556482 |
| 23 | NUCKS1_24931609_ChIP-Seq_HEPATOCYTES_Mouse | 1.63141314 |
| 24 | KDM2B_26808549_Chip-Seq_DND41_Human | 1.61006782 |
| 25 | BACH1_22875853_ChIP-PCR_HELA_AND_SCP4_Human | 1.58611402 |
| 26 | TCF21_26020271_ChIP-Seq_SMOOTH_MUSCLE_Human | 1.58224941 |
| 27 | ZNF274_21170338_ChIP-Seq_K562_Hela | 1.57607337 |
| 28 | ESR2_21235772_ChIP-Seq_MCF-7_Human | 1.57450980 |
| 29 | TBP_23326641_ChIP-Seq_C3H10T1-2_Mouse | 1.56719260 |
| 30 | ESR1_17901129_ChIP-ChIP_LIVER_Mouse | 1.53819182 |
| 31 | PBX_27287812_Chip-Seq_EMBYONIC-LIMB_Mouse | 1.50118992 |
| 32 | CLOCK_20551151_ChIP-Seq_293T_Human | 1.49790339 |
| 33 | SOX9_25088423_ChIP-ChIP_EMBRYONIC_GONADS_Mouse | 1.48313993 |
| 34 | SA1_27219007_Chip-Seq_Bcells_Human | 1.43513303 |
| 35 | NR1I2_20693526_ChIP-Seq_LIVER_Mouse | 1.40117705 |
| 36 | PPARA_22158963_ChIP-Seq_LIVER_Mouse | 1.37188624 |
| 37 | EWS-FLI1_20517297_ChIP-Seq_SK-N-MC_Human | 1.36612202 |
| 38 | RUNX2_24764292_ChIP-Seq_MC3T3_Mouse | 1.36530735 |
| 39 | LYL1_20887958_ChIP-Seq_HPC-7_Mouse | 1.35794224 |
| 40 | ZFP281_18757296_ChIP-ChIP_E14_Mouse | 1.34314188 |
| 41 | CTCF_21964334_Chip-Seq_Bcells_Human | 1.32483314 |
| 42 | TCF7_22412390_ChIP-Seq_EML_Mouse | 1.32100378 |
| 43 | FOXH1_21741376_ChIP-Seq_ESCs_Human | 1.29891467 |
| 44 | CTNNB1_24651522_ChIP-Seq_LGR5+_INTESTINAL_STEM_Human | 1.29885623 |
| 45 | EP300_21415370_ChIP-Seq_HL-1_Mouse | 1.29763347 |
| 46 | LXR_22292898_ChIP-Seq_THP-1_Human | 1.27641310 |
| 47 | P63_26484246_Chip-Seq_KERATINOCYTES_Human | 1.26112264 |
| 48 | * DNAJC2_21179169_ChIP-ChIP_NT2_Human | 1.25969324 |
| 49 | GATA1_19941827_ChIP-Seq_MEL_Mouse | 1.25656065 |
| 50 | DROSHA_22980978_ChIP-Seq_HELA_Human | 1.23555127 |
| 51 | SMC1_22415368_ChIP-Seq_MEFs_Mouse | 1.23441998 |
| 52 | KDM2B_26808549_Chip-Seq_SUP-B15_Human | 1.23038777 |
| 53 | LMO2_20887958_ChIP-Seq_HPC-7_Mouse | 1.22084996 |
| 54 | CTCF_27219007_Chip-Seq_ERYTHROID_Human | 1.21765286 |
| 55 | CREB1_26743006_Chip-Seq_LNCaP_Human | 1.20104992 |
| 56 | UBF1/2_26484160_Chip-Seq_HMEC-DERIVED_Human | 1.17490410 |
| 57 | OCT4_20526341_ChIP-Seq_ESCs_Human | 1.16353167 |
| 58 | GATA2_26923725_Chip-Seq_HEMANGIOBLAST_Mouse | 1.16287034 |
| 59 | STAT3_19079543_ChIP-ChIP_MESCs_Mouse | 1.16257486 |
| 60 | RACK7_27058665_Chip-Seq_MCF-7_Human | 1.15866403 |
| 61 | TDRD3_21172665_ChIP-Seq_MCF-7_Human | 1.14806555 |
| 62 | SMC3_22415368_ChIP-Seq_MEFs_Mouse | 1.13739343 |
| 63 | NR0B1_18358816_ChIP-ChIP_MESCs_Mouse | 1.12446685 |
| 64 | STAT1_20625510_ChIP-Seq_HELA_Human | 1.11647542 |
| 65 | MYCN_19997598_ChIP-ChIP_NEUROBLASTOMA_Human | 1.10855116 |
| 66 | TFAP2C_20629094_ChIP-Seq_MCF-7_Human | 1.10519527 |
| 67 | CBP_20019798_ChIP-Seq_JUKART_Human | 1.10441524 |
| 68 | IRF4_20064451_ChIP-Seq_CD4+T_Mouse | 1.10441524 |
| 69 | RXR_22158963_ChIP-Seq_LIVER_Mouse | 1.08824523 |
| 70 | VDR_21846776_ChIP-Seq_THP-1_Human | 1.08180924 |
| 71 | GATA4_21415370_ChIP-Seq_HL-1_Mouse | 1.07860292 |
| 72 | P300_27058665_Chip-Seq_ZR-75-30cells_Human | 1.07228498 |
| 73 | P68_20966046_ChIP-Seq_HELA_Human | 1.07126749 |
| 74 | E4F1_26484288_ChIP-Seq_MOUSE_EMBRYONIC_FIBROBLAST_Mouse | 1.06430777 |
| 75 | MYCN_27167114_Chip-Seq_NEUROBLASTOMA_Human | 1.06373433 |
| 76 | YY1_22570637_ChIP-Seq_MALME-3M_Human | 1.06259463 |
| 77 | * WT1_20215353_ChIP-ChIP_NEPHRON_PROGENITOR_Mouse | 1.04992617 |
| 78 | SRY_25088423_ChIP-ChIP_EMBRYONIC_GONADS_Mouse | 1.03939790 |
| 79 | ERG_21242973_ChIP-ChIP_JURKAT_Human | 1.03343494 |
| 80 | NKX2-5_21415370_ChIP-Seq_HL-1_Mouse | 1.03221872 |
| 81 | SMAD2/3_21741376_ChIP-Seq_ESCs_Human | 1.02274581 |
| 82 | EZH2_27294783_Chip-Seq_ESCs_Mouse | 1.02251363 |
| 83 | ELF1_20517297_ChIP-Seq_JURKAT_Human | 1.01996838 |
| 84 | KDM2B_26808549_Chip-Seq_HPB-ALL_Human | 1.01916152 |
| 85 | KLF6_26769127_Chip-Seq_PDAC-Cell_line_Human | 1.01272144 |
| 86 | RAC3_21632823_ChIP-Seq_H3396_Human | 1.00341315 |
| 87 | ELF3_26769127_Chip-Seq_PDAC-Cell_line_Human | 1.00272839 |
| 88 | TP53_20018659_ChIP-ChIP_R1E_Mouse | 1.00262166 |
| 89 | FOXP2_23625967_ChIP-Seq_PFSK-1_AND_SK-N-MC_Human | 0.99865691 |
| 90 | CTCF_26484167_Chip-Seq_Bcells_Mouse | 0.99791921 |
| 91 | ATF3_27146783_Chip-Seq_COLON_Human | 0.99471711 |
| 92 | KDM2B_26808549_Chip-Seq_K562_Human | 0.97649868 |
| 93 | LXR_22158963_ChIP-Seq_LIVER_Mouse | 0.96630536 |
| 94 | NFIB_24661679_ChIP-Seq_LUNG_Mouse | 0.96249706 |
| 95 | SA1_27219007_Chip-Seq_ERYTHROID_Human | 0.96228559 |
| 96 | ELK3_25401928_ChIP-Seq_HUVEC_Human | 0.95691539 |
| 97 | ESR1_15608294_ChIP-ChIP_MCF-7_Human | 0.95047609 |
| 98 | RAD21_21589869_ChIP-Seq_MESCs_Mouse | 0.93425507 |
| 99 | KLF4_26769127_Chip-Seq_PDAC-Cell_line_Human | 0.93006246 |
| 100 | RARB_27405468_Chip-Seq_BRAIN_Mouse | 0.92702134 |
| 101 | FOXO1_23066095_ChIP-Seq_LIVER_Mouse | 0.92521959 |
| 102 | MAF_26560356_Chip-Seq_TH1_Human | 0.92311353 |
| 103 | STAT3_22323479_ChIP-Seq_MACROPHAGE_Mouse | 0.92297351 |
| 104 | STAT6_21828071_ChIP-Seq_BEAS2B_Human | 0.92083648 |
| 105 | * MYC_27129775_Chip-Seq_CORNEA_Mouse | 0.91799334 |
| 106 | E2F1_20622854_ChIP-Seq_HELA_Human | 0.91776100 |
| 107 | * EGR1_20690147_ChIP-Seq_ERYTHROLEUKEMIA_Human | 0.91171106 |
| 108 | EZH2_22144423_ChIP-Seq_EOC_Human | 0.90919793 |
| 109 | ATF3_23680149_ChIP-Seq_GBM1-GSC_Human | 0.89677606 |
| 110 | SREBP1_19666523_ChIP-Seq_LIVER_Mouse | 0.89020917 |
| 111 | CEBPB_22108803_ChIP-Seq_LS180_Human | 0.88641386 |
| 112 | BCL6_27268052_Chip-Seq_Bcells_Human | 0.88606523 |
| 113 | NANOG_20526341_ChIP-Seq_ESCs_Human | 0.88438862 |
| 114 | GATA6_21074721_ChIP-Seq_CACO-2_Mouse | 0.88341754 |
| 115 | VDR_24787735_ChIP-Seq_THP-1_Human | 0.87652341 |
| 116 | KDM2B_26808549_Chip-Seq_SIL-ALL_Human | 0.87482168 |
| 117 | EP300_20729851_ChIP-Seq_FORBRAIN_MIDBRAIN_LIMB_HEART_Mouse | 0.87081080 |
| 118 | KLF4_19829295_ChIP-Seq_ESCs_Human | 0.86289646 |
| 119 | P63_20808887_ChIP-Seq_KERATINOCYTES_Human | 0.86210173 |
| 120 | SPI1_20517297_ChIP-Seq_HL60_Human | 0.85999384 |
| 121 | STAT3_1855785_ChIP-Seq_MESCs_Mouse | 0.84430854 |
| 122 | GATA1_19941827_ChIP-Seq_MEL86_Mouse | 0.83064794 |
| 123 | SPI1_23127762_ChIP-Seq_K562_Human | 0.82771241 |
| 124 | SMC4_20622854_ChIP-Seq_HELA_Human | 0.82188410 |
| 125 | SPI1_20176806_ChIP-Seq_THIOMACROPHAGE_Mouse | 0.79984078 |
| 126 | PU.1_20176806_ChIP-Seq_MACROPHAGES_Mouse | 0.79328701 |
| 127 | EGR1_19032775_ChIP-ChIP_M12_Human | 0.76671014 |
| 128 | * PU.1_20513432_ChIP-Seq_MACROPHAGES_Mouse | 0.76525072 |
| 129 | DPY_21335234_ChIP-Seq_ESCs_Mouse | 0.75597076 |
| 130 | OCT4_19829295_ChIP-Seq_ESCs_Human | 0.74392315 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | MP0004145_abnormal_muscle_electrophysio | 8.09648493 |
| 2 | MP0000749_muscle_degeneration | 6.52720223 |
| 3 | MP0003646_muscle_fatigue | 6.13217778 |
| 4 | MP0000751_myopathy | 5.82083920 |
| 5 | MP0000747_muscle_weakness | 4.62035593 |
| 6 | MP0002106_abnormal_muscle_physiology | 4.30891900 |
| 7 | MP0000759_abnormal_skeletal_muscle | 3.93937855 |
| 8 | MP0004036_abnormal_muscle_relaxation | 3.90319941 |
| 9 | MP0005451_abnormal_body_composition | 3.85080757 |
| 10 | MP0002269_muscular_atrophy | 3.63364831 |
| 11 | MP0005369_muscle_phenotype | 3.58901178 |
| 12 | MP0000750_abnormal_muscle_regeneration | 3.50172127 |
| 13 | MP0004087_abnormal_muscle_fiber | 3.47458256 |
| 14 | MP0002837_dystrophic_cardiac_calcinosis | 3.32919998 |
| 15 | MP0004130_abnormal_muscle_cell | 3.12075505 |
| 16 | MP0005620_abnormal_muscle_contractility | 3.05473451 |
| 17 | MP0000733_abnormal_muscle_development | 2.86856840 |
| 18 | MP0004233_abnormal_muscle_weight | 2.75069274 |
| 19 | MP0002108_abnormal_muscle_morphology | 2.14810317 |
| 20 | MP0002332_abnormal_exercise_endurance | 2.11934818 |
| 21 | MP0005330_cardiomyopathy | 1.81460483 |
| 22 | MP0004270_analgesia | 1.75936269 |
| 23 | MP0006036_abnormal_mitochondrial_physio | 1.73214635 |
| 24 | MP0004185_abnormal_adipocyte_glucose | 1.62747533 |
| 25 | MP0004084_abnormal_cardiac_muscle | 1.59921253 |
| 26 | MP0002971_abnormal_brown_adipose | 1.53960238 |
| 27 | MP0005666_abnormal_adipose_tissue | 1.33218683 |
| 28 | MP0004215_abnormal_myocardial_fiber | 1.27278828 |
| 29 | MP0002972_abnormal_cardiac_muscle | 1.21079872 |
| 30 | MP0004484_altered_response_of | 1.20675946 |
| 31 | MP0010630_abnormal_cardiac_muscle | 1.19200641 |
| 32 | MP0000013_abnormal_adipose_tissue | 1.18634272 |
| 33 | MP0003806_abnormal_nucleotide_metabolis | 1.12984834 |
| 34 | MP0003221_abnormal_cardiomyocyte_apopto | 1.12768117 |
| 35 | MP0005375_adipose_tissue_phenotype | 1.05245592 |
| 36 | MP0005266_abnormal_metabolism | 1.02106298 |
| 37 | MP0003950_abnormal_plasma_membrane | 1.01109187 |
| 38 | MP0004134_abnormal_chest_morphology | 0.98195028 |
| 39 | MP0001661_extended_life_span | 0.95880644 |
| 40 | MP0006035_abnormal_mitochondrial_morpho | 0.93382970 |
| 41 | MP0003705_abnormal_hypodermis_morpholog | 0.91346980 |
| 42 | MP0002822_catalepsy | 0.87245873 |
| 43 | MP0002234_abnormal_pharynx_morphology | 0.83002824 |
| 44 | MP0008961_abnormal_basal_metabolism | 0.82104335 |
| 45 | MP0001544_abnormal_cardiovascular_syste | 0.80560555 |
| 46 | MP0005385_cardiovascular_system_phenoty | 0.80560555 |
| 47 | MP0001299_abnormal_eye_distance/ | 0.78271261 |
| 48 | MP0003656_abnormal_erythrocyte_physiolo | 0.75079123 |
| 49 | MP0003137_abnormal_impulse_conducting | 0.72511986 |
| 50 | MP0003879_abnormal_hair_cell | 0.71202703 |
| 51 | MP0009250_abnormal_appendicular_skeleto | 0.70082522 |
| 52 | MP0000003_abnormal_adipose_tissue | 0.65178431 |
| 53 | MP0000372_irregular_coat_pigmentation | 0.60321230 |
| 54 | MP0004147_increased_porphyrin_level | 0.60313822 |
| 55 | MP0002078_abnormal_glucose_homeostasis | 0.58600755 |
| 56 | MP0005334_abnormal_fat_pad | 0.57331000 |
| 57 | MP0000762_abnormal_tongue_morphology | 0.56372598 |
| 58 | MP0005058_abnormal_lysosome_morphology | 0.54782256 |
| 59 | MP0005670_abnormal_white_adipose | 0.54761940 |
| 60 | MP0004043_abnormal_pH_regulation | 0.53203637 |
| 61 | MP0009840_abnormal_foam_cell | 0.52767362 |
| 62 | MP0005275_abnormal_skin_tensile | 0.52676786 |
| 63 | MP0005167_abnormal_blood-brain_barrier | 0.52623729 |
| 64 | MP0000266_abnormal_heart_morphology | 0.51889613 |
| 65 | MP0005083_abnormal_biliary_tract | 0.49321858 |
| 66 | MP0008569_lethality_at_weaning | 0.48573058 |
| 67 | MP0000343_altered_response_to | 0.46905261 |
| 68 | MP0005452_abnormal_adipose_tissue | 0.46157425 |
| 69 | MP0002127_abnormal_cardiovascular_syste | 0.45097688 |
| 70 | MP0002089_abnormal_postnatal_growth/wei | 0.44398085 |
| 71 | MP0005584_abnormal_enzyme/coenzyme_acti | 0.43077943 |
| 72 | MP0008775_abnormal_heart_ventricle | 0.42918085 |
| 73 | MP0002896_abnormal_bone_mineralization | 0.42147321 |
| 74 | MP0004858_abnormal_nervous_system | 0.41507660 |
| 75 | MP0003045_fibrosis | 0.41292407 |
| 76 | MP0003959_abnormal_lean_body | 0.40803841 |
| 77 | MP0002114_abnormal_axial_skeleton | 0.40030265 |
| 78 | MP0005319_abnormal_enzyme/_coenzyme | 0.37352665 |
| 79 | MP0009672_abnormal_birth_weight | 0.36870537 |
| 80 | MP0004510_myositis | 0.33282486 |
| 81 | MP0003948_abnormal_gas_homeostasis | 0.32938040 |
| 82 | MP0006138_congestive_heart_failure | 0.32819576 |
| 83 | MP0009780_abnormal_chondrocyte_physiolo | 0.32065846 |
| 84 | MP0002249_abnormal_larynx_morphology | 0.30680371 |
| 85 | MP0001849_ear_inflammation | 0.30628753 |
| 86 | MP0002734_abnormal_mechanical_nocicepti | 0.30336215 |
| 87 | MP0009115_abnormal_fat_cell | 0.30169108 |
| 88 | MP0010030_abnormal_orbit_morphology | 0.28520963 |
| 89 | MP0004142_abnormal_muscle_tone | 0.27940480 |
| 90 | MP0001943_abnormal_respiration | 0.26673103 |
| 91 | MP0005165_increased_susceptibility_to | 0.25835826 |
| 92 | MP0003828_pulmonary_edema | 0.25656960 |
| 93 | MP0001243_abnormal_dermal_layer | 0.24913350 |
| 94 | MP0008770_decreased_survivor_rate | 0.23888145 |
| 95 | MP0005076_abnormal_cell_differentiation | 0.23422020 |
| 96 | MP0005376_homeostasis/metabolism_phenot | 0.22634159 |
| 97 | MP0005166_decreased_susceptibility_to | 0.22229225 |
| 98 | MP0004085_abnormal_heartbeat | 0.22060060 |
| 99 | MP0005503_abnormal_tendon_morphology | 0.21481832 |
| 100 | MP0001346_abnormal_lacrimal_gland | 0.21351572 |
| 101 | MP0002932_abnormal_joint_morphology | 0.21236289 |
| 102 | MP0005535_abnormal_body_temperature | 0.21215030 |
| 103 | MP0002128_abnormal_blood_circulation | 0.21093479 |
| 104 | MP0000230_abnormal_systemic_arterial | 0.20100567 |
| 105 | MP0002066_abnormal_motor_capabilities/c | 0.19590231 |
| 106 | MP0002118_abnormal_lipid_homeostasis | 0.19007384 |
| 107 | MP0003567_abnormal_fetal_cardiomyocyte | 0.18974705 |
| 108 | MP0003075_altered_response_to | 0.17775010 |
| 109 | MP0002970_abnormal_white_adipose | 0.17710768 |
| 110 | MP0008874_decreased_physiological_sensi | 0.17623583 |
| 111 | MP0005332_abnormal_amino_acid | 0.17330200 |
| 112 | MP0004197_abnormal_fetal_growth/weight/ | 0.17102232 |
| 113 | MP0003385_abnormal_body_wall | 0.15871324 |
| 114 | MP0002638_abnormal_pupillary_reflex | 0.15144540 |
| 115 | MP0003195_calcinosis | 0.15129174 |
| 116 | MP0001542_abnormal_bone_strength | 0.13690622 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | Muscle fiber cytoplasmatic inclusion bodies (HP:0100303) | 9.91865181 |
| 2 | Nemaline bodies (HP:0003798) | 9.38353457 |
| 3 | Exercise-induced myalgia (HP:0003738) | 8.25951406 |
| 4 | Type 1 muscle fiber predominance (HP:0003803) | 7.68724800 |
| 5 | Exercise-induced muscle cramps (HP:0003710) | 7.55877477 |
| 6 | Distal arthrogryposis (HP:0005684) | 7.47034269 |
| 7 | Muscle hypertrophy of the lower extremities (HP:0008968) | 6.73823275 |
| 8 | Round ear (HP:0100830) | 6.35111125 |
| 9 | Ulnar deviation of the wrist (HP:0003049) | 6.31368456 |
| 10 | Calf muscle hypertrophy (HP:0008981) | 5.98640105 |
| 11 | * Myopathic facies (HP:0002058) | 5.55046181 |
| 12 | Difficulty running (HP:0009046) | 5.54577613 |
| 13 | Calcaneovalgus deformity (HP:0001848) | 5.42040226 |
| 14 | Muscle fiber splitting (HP:0003555) | 5.13309734 |
| 15 | Absent phalangeal crease (HP:0006109) | 5.03585707 |
| 16 | Deformed tarsal bones (HP:0008119) | 4.95809637 |
| 17 | Myoglobinuria (HP:0002913) | 4.83272228 |
| 18 | Hyporeflexia of lower limbs (HP:0002600) | 4.73655956 |
| 19 | EMG: myopathic abnormalities (HP:0003458) | 4.56161009 |
| 20 | Muscle stiffness (HP:0003552) | 4.55801872 |
| 21 | Increased connective tissue (HP:0009025) | 4.27722022 |
| 22 | Abnormal finger flexion creases (HP:0006143) | 4.21484665 |
| 23 | Abnormality of the calf musculature (HP:0001430) | 4.13458713 |
| 24 | Rhabdomyolysis (HP:0003201) | 4.09292662 |
| 25 | Myotonia (HP:0002486) | 4.04226489 |
| 26 | Abnormality of skeletal muscle fiber size (HP:0012084) | 3.91415887 |
| 27 | Difficulty climbing stairs (HP:0003551) | 3.58099166 |
| 28 | Neck muscle weakness (HP:0000467) | 3.49744893 |
| 29 | Increased variability in muscle fiber diameter (HP:0003557) | 3.43493104 |
| 30 | Abnormality of the left ventricular outflow tract (HP:0011103) | 3.36190344 |
| 31 | Subaortic stenosis (HP:0001682) | 3.36190344 |
| 32 | Abnormality of the calcaneus (HP:0008364) | 3.31120068 |
| 33 | Rimmed vacuoles (HP:0003805) | 3.28265384 |
| 34 | Pelvic girdle muscle weakness (HP:0003749) | 3.26447196 |
| 35 | Frequent falls (HP:0002359) | 3.25787046 |
| 36 | Shoulder girdle muscle weakness (HP:0003547) | 3.25375389 |
| 37 | * Malignant hyperthermia (HP:0002047) | 3.19586382 |
| 38 | Abnormality of the hip-girdle musculature (HP:0001445) | 3.14982506 |
| 39 | Abnormality of the musculature of the pelvis (HP:0001469) | 3.14982506 |
| 40 | Abnormality of the neuromuscular junction (HP:0003398) | 3.14786114 |
| 41 | Fatigable weakness (HP:0003473) | 3.14786114 |
| 42 | Areflexia of lower limbs (HP:0002522) | 3.05557808 |
| 43 | Hyperkalemia (HP:0002153) | 2.84957396 |
| 44 | Fetal akinesia sequence (HP:0001989) | 2.75072101 |
| 45 | Asymmetric septal hypertrophy (HP:0001670) | 2.71849231 |
| 46 | Slender build (HP:0001533) | 2.70901812 |
| 47 | Bundle branch block (HP:0011710) | 2.63263304 |
| 48 | Bulbar palsy (HP:0001283) | 2.52903676 |
| 49 | EMG: neuropathic changes (HP:0003445) | 2.52213027 |
| 50 | Distal lower limb muscle weakness (HP:0009053) | 2.50836855 |
| 51 | Mildly elevated creatine phosphokinase (HP:0008180) | 2.47934110 |
| 52 | Weak cry (HP:0001612) | 2.47710780 |
| 53 | Paralysis (HP:0003470) | 2.41829058 |
| 54 | Gowers sign (HP:0003391) | 2.41820816 |
| 55 | Generalized muscle weakness (HP:0003324) | 2.40581907 |
| 56 | Sudden death (HP:0001699) | 2.39342274 |
| 57 | Dilated cardiomyopathy (HP:0001644) | 2.36749085 |
| 58 | Proximal amyotrophy (HP:0007126) | 2.31966401 |
| 59 | Muscular dystrophy (HP:0003560) | 2.30963509 |
| 60 | Centrally nucleated skeletal muscle fibers (HP:0003687) | 2.29583406 |
| 61 | Hypoplastic ischia (HP:0003175) | 2.29008036 |
| 62 | Limb-girdle muscle weakness (HP:0003325) | 2.23731382 |
| 63 | Facial diplegia (HP:0001349) | 2.23630502 |
| 64 | Nonprogressive disorder (HP:0003680) | 2.23093823 |
| 65 | Distal lower limb amyotrophy (HP:0008944) | 2.22680480 |
| 66 | Scapular winging (HP:0003691) | 2.16295969 |
| 67 | Ulnar deviation of finger (HP:0009465) | 2.13246476 |
| 68 | Spinal rigidity (HP:0003306) | 2.13200915 |
| 69 | Metatarsus adductus (HP:0001840) | 2.13058820 |
| 70 | Abnormality of the shoulder girdle musculature (HP:0001435) | 2.11477116 |
| 71 | Abnormality of the foot musculature (HP:0001436) | 2.09240651 |
| 72 | Amniotic constriction ring (HP:0009775) | 2.07124397 |
| 73 | Abnormality of placental membranes (HP:0011409) | 2.07124397 |
| 74 | Limb-girdle muscle atrophy (HP:0003797) | 2.06298578 |
| 75 | Progressive muscle weakness (HP:0003323) | 2.05933206 |
| 76 | Lipoatrophy (HP:0100578) | 2.04724654 |
| 77 | Muscle fiber inclusion bodies (HP:0100299) | 10.3576159 |
| 78 | Type 2 muscle fiber atrophy (HP:0003554) | 1.99796030 |
| 79 | Abnormality of the ischium (HP:0003174) | 1.98819088 |
| 80 | Aplasia/Hypoplasia of the pubic bone (HP:0009104) | 1.98361491 |
| 81 | Hip contracture (HP:0003273) | 1.97963911 |
| 82 | Foot dorsiflexor weakness (HP:0009027) | 1.97608968 |
| 83 | Waddling gait (HP:0002515) | 1.88079813 |
| 84 | Increased density of long bones (HP:0006392) | 1.81964352 |
| 85 | Achilles tendon contracture (HP:0001771) | 1.81899206 |
| 86 | Muscle fiber atrophy (HP:0100295) | 1.80843128 |
| 87 | Heart block (HP:0012722) | 1.74319392 |
| 88 | Ragged-red muscle fibers (HP:0003200) | 1.70560768 |
| 89 | Ulnar deviation of the hand or of fingers of the hand (HP:0001193) | 1.70463885 |
| 90 | Tarsal synostosis (HP:0008368) | 1.69854830 |
| 91 | Respiratory insufficiency due to muscle weakness (HP:0002747) | 1.67799859 |
| 92 | Lower limb amyotrophy (HP:0007210) | 1.66860570 |
| 93 | Abnormality of the Achilles tendon (HP:0005109) | 1.66089809 |
| 94 | Long clavicles (HP:0000890) | 1.65308486 |
| 95 | Abnormal atrioventricular conduction (HP:0005150) | 1.65249999 |
| 96 | Exercise intolerance (HP:0003546) | 1.64451616 |
| 97 | Easy fatigability (HP:0003388) | 1.59396001 |
| 98 | Cholelithiasis (HP:0001081) | 1.57183262 |
| 99 | Stridor (HP:0010307) | 1.55423467 |
| 100 | Adducted thumb (HP:0001181) | 1.54531260 |
| 101 | Synostosis involving bones of the feet (HP:0009140) | 1.51742676 |
| 102 | Synostosis involving bones of the lower limbs (HP:0009138) | 1.51742676 |
| 103 | Ventricular arrhythmia (HP:0004308) | 1.51296080 |
| 104 | Ventricular tachycardia (HP:0004756) | 1.50083079 |
| 105 | Congenital hip dislocation (HP:0001374) | 1.49152416 |
| 106 | Abnormality of potassium homeostasis (HP:0011042) | 1.45677527 |
| 107 | Aplasia of the musculature (HP:0100854) | 1.45675145 |
| 108 | Hyperuricemia (HP:0002149) | 1.41630139 |
| 109 | Increased purine levels (HP:0004368) | 1.41630139 |
| 110 | Popliteal pterygium (HP:0009756) | 1.40162434 |
| 111 | Gout (HP:0001997) | 1.40099096 |
| 112 | Abnormal gallbladder morphology (HP:0012437) | 1.38176907 |
| 113 | Steppage gait (HP:0003376) | 1.37921310 |
| 114 | Generalized amyotrophy (HP:0003700) | 1.35319566 |
| 115 | Increased intramyocellular lipid droplets (HP:0012240) | 1.34843288 |
| 116 | Limited hip movement (HP:0008800) | 1.33560071 |
| 117 | Increased muscle lipid content (HP:0009058) | 1.33238032 |
| 118 | Diaphragmatic weakness (HP:0009113) | 1.31293536 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | OBSCN | 8.85623464 |
| 2 | TTN | 6.38039990 |
| 3 | PHKG1 | 5.18692769 |
| 4 | PHKG2 | 5.18692769 |
| 5 | NME1 | 4.18653946 |
| 6 | PIK3CG | 4.04123835 |
| 7 | MAP2K3 | 2.90924602 |
| 8 | NEK1 | 2.32227589 |
| 9 | MAP3K7 | 2.26396171 |
| 10 | TRIB3 | 2.15077764 |
| 11 | PINK1 | 1.97955102 |
| 12 | MUSK | 1.89011050 |
| 13 | DMPK | 1.75979887 |
| 14 | PDK4 | 1.74761999 |
| 15 | PDK3 | 1.74761999 |
| 16 | MAPK12 | 1.67585107 |
| 17 | MAP2K4 | 1.61224845 |
| 18 | PIK3CA | 1.41975023 |
| 19 | BCKDK | 1.39193675 |
| 20 | MAP2K6 | 1.36532564 |
| 21 | PDK2 | 1.09251245 |
| 22 | MAP3K13 | 1.07516320 |
| 23 | TAOK2 | 0.88710583 |
| 24 | MOS | 0.88690793 |
| 25 | PRKAA2 | 0.82683172 |
| 26 | PKN2 | 0.81923081 |
| 27 | MAP3K3 | 0.80674915 |
| 28 | NEK9 | 0.78554891 |
| 29 | PRKAA1 | 0.76469060 |
| 30 | RIPK1 | 0.75232071 |
| 31 | ERBB3 | 0.70597571 |
| 32 | AKT2 | 0.70376488 |
| 33 | MAPKAPK3 | 0.68588746 |
| 34 | TRPM7 | 0.65230647 |
| 35 | MARK3 | 0.64570339 |
| 36 | EPHB1 | 0.62401161 |
| 37 | MAPK11 | 0.61050279 |
| 38 | MARK1 | 0.59437347 |
| 39 | CAMK4 | 0.57562838 |
| 40 | SIK1 | 0.56854746 |
| 41 | PRPF4B | 0.56514591 |
| 42 | TAOK1 | 0.54419597 |
| 43 | MAP3K10 | 0.54209102 |
| 44 | TBK1 | 0.54156179 |
| 45 | STK24 | 0.53931567 |
| 46 | MAP3K11 | 0.52162408 |
| 47 | CAMK2G | 0.52033717 |
| 48 | EEF2K | 0.50970226 |
| 49 | PTK6 | 0.50331284 |
| 50 | ARAF | 0.48751352 |
| 51 | ILK | 0.47818511 |
| 52 | LIMK1 | 0.40506103 |
| 53 | ZAK | 0.40249182 |
| 54 | MAP2K1 | 0.38467666 |
| 55 | KSR2 | 0.37783158 |
| 56 | MAP3K5 | 0.35118285 |
| 57 | CAMK1 | 0.34012194 |
| 58 | SGK1 | 0.32071078 |
| 59 | SGK2 | 0.31115955 |
| 60 | RPS6KB1 | 0.30563772 |
| 61 | EPHA3 | 0.29131661 |
| 62 | CAMK2A | 0.28966105 |
| 63 | MARK2 | 0.28722103 |
| 64 | CAMK2B | 0.28006057 |
| 65 | PRKG1 | 0.27884432 |
| 66 | RPS6KA3 | 0.26301071 |
| 67 | PAK6 | 0.26215340 |
| 68 | MAPK7 | 0.24969833 |
| 69 | MAP3K6 | 0.24815137 |
| 70 | PRKACB | 0.24639232 |
| 71 | ZAP70 | 0.24136258 |
| 72 | ERN1 | 0.24009693 |
| 73 | CAMK1G | 0.23072595 |
| 74 | MAP3K1 | 0.22702557 |
| 75 | TNK2 | 0.22474038 |
| 76 | ROCK1 | 0.21896902 |
| 77 | PKN1 | 0.21480370 |
| 78 | CDK19 | 0.21146191 |
| 79 | TYK2 | 0.21078805 |
| 80 | MAPK4 | 0.20880253 |
| 81 | DYRK1B | 0.19576817 |
| 82 | RPS6KL1 | 0.18909230 |
| 83 | RPS6KC1 | 0.18909230 |
| 84 | ICK | 0.16729815 |
| 85 | RPS6KB2 | 0.16467254 |
| 86 | PDPK1 | 0.16231415 |
| 87 | MAP3K9 | 0.15948499 |
| 88 | BRAF | 0.15748827 |
| 89 | BMX | 0.14792035 |
| 90 | BLK | 0.14037697 |
| 91 | SGK494 | 0.13935085 |
| 92 | SGK223 | 0.13935085 |
| 93 | PDK1 | 0.13392418 |
| 94 | PRKACA | 0.13215467 |
| 95 | LRRK2 | 0.13214163 |
| 96 | MTOR | 0.12887062 |
| 97 | RPS6KA6 | 0.12662600 |
| 98 | PRKD1 | 0.11830350 |
| 99 | CDC42BPA | 0.11519401 |
| 100 | RAF1 | 0.11056893 |
| 101 | MAPK10 | 0.10172101 |
| 102 | MAPK13 | 0.09757164 |
| 103 | DAPK2 | 0.09755773 |
| 104 | LATS1 | 0.08582561 |
| 105 | RPS6KA2 | 0.08516543 |
| 106 | KSR1 | 0.08279179 |
| 107 | FGFR1 | 0.08206278 |
| 108 | RPS6KA1 | 0.07479998 |
| 109 | FGFR4 | 0.07118297 |
| 110 | SGK3 | 0.06879462 |
| 111 | ROCK2 | 0.06850525 |
| 112 | PRKG2 | 0.05795684 |
| 113 | CCNB1 | 0.05420022 |
| 114 | PTK2B | 0.04849685 |
| 115 | JAK2 | 0.04220913 |
| 116 | MAPK8 | 0.03344230 |
| 117 | PAK4 | 0.03259071 |
| 118 | STK11 | 0.02753987 |
| 119 | CAMK2D | 0.02745398 |
| 120 | MAPK9 | 0.02240422 |
| 121 | TGFBR2 | 0.02169804 |
| 122 | LATS2 | 0.02057233 |
| 123 | PDGFRA | 0.01718820 |
| 124 | CDK6 | 0.01373193 |
| 125 | CSNK1D | 0.01181134 |
| 126 | PRKACG | 0.00994265 |
| 127 | HCK | -0.0116477 |
| 128 | PRKCH | -0.0111857 |
| 129 | TIE1 | -0.0105855 |
| 130 | GSK3A | -0.0096511 |
| 131 | INSRR | -0.0026050 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | Hypertrophic cardiomyopathy (HCM)_Homo sapiens_hsa05410 | 4.41126162 |
| 2 | Citrate cycle (TCA cycle)_Homo sapiens_hsa00020 | 4.03983826 |
| 3 | Arrhythmogenic right ventricular cardiomyopathy (ARVC)_Homo sapiens_hsa05412 | 3.85995060 |
| 4 | Dilated cardiomyopathy_Homo sapiens_hsa05414 | 3.60369117 |
| 5 | Cardiac muscle contraction_Homo sapiens_hsa04260 | 3.50510366 |
| 6 | 2-Oxocarboxylic acid metabolism_Homo sapiens_hsa01210 | 3.19166312 |
| 7 | Starch and sucrose metabolism_Homo sapiens_hsa00500 | 2.96105580 |
| 8 | Circadian rhythm_Homo sapiens_hsa04710 | 2.42111799 |
| 9 | Glucagon signaling pathway_Homo sapiens_hsa04922 | 2.42076444 |
| 10 | Oxytocin signaling pathway_Homo sapiens_hsa04921 | 2.39675435 |
| 11 | Insulin signaling pathway_Homo sapiens_hsa04910 | 2.34264128 |
| 12 | Phenylalanine, tyrosine and tryptophan biosynthesis_Homo sapiens_hsa00400 | 2.24874024 |
| 13 | Insulin resistance_Homo sapiens_hsa04931 | 2.10775518 |
| 14 | Carbon metabolism_Homo sapiens_hsa01200 | 2.07517579 |
| 15 | Propanoate metabolism_Homo sapiens_hsa00640 | 2.03647429 |
| 16 | Glycolysis / Gluconeogenesis_Homo sapiens_hsa00010 | 2.00150836 |
| 17 | Adrenergic signaling in cardiomyocytes_Homo sapiens_hsa04261 | 1.86637502 |
| 18 | Adipocytokine signaling pathway_Homo sapiens_hsa04920 | 1.81693355 |
| 19 | AMPK signaling pathway_Homo sapiens_hsa04152 | 1.73489992 |
| 20 | Galactose metabolism_Homo sapiens_hsa00052 | 1.67758538 |
| 21 | Calcium signaling pathway_Homo sapiens_hsa04020 | 1.67482688 |
| 22 | Nicotinate and nicotinamide metabolism_Homo sapiens_hsa00760 | 1.61111935 |
| 23 | Viral myocarditis_Homo sapiens_hsa05416 | 1.51758147 |
| 24 | Fructose and mannose metabolism_Homo sapiens_hsa00051 | 1.50686869 |
| 25 | Biosynthesis of amino acids_Homo sapiens_hsa01230 | 1.49379778 |
| 26 | Longevity regulating pathway - multiple species_Homo sapiens_hsa04213 | 1.41674422 |
| 27 | Tight junction_Homo sapiens_hsa04530 | 1.32724222 |
| 28 | Pyruvate metabolism_Homo sapiens_hsa00620 | 1.29853418 |
| 29 | Alzheimers disease_Homo sapiens_hsa05010 | 1.27797607 |
| 30 | Parkinsons disease_Homo sapiens_hsa05012 | 1.25216553 |
| 31 | Non-alcoholic fatty liver disease (NAFLD)_Homo sapiens_hsa04932 | 1.24834122 |
| 32 | Fatty acid degradation_Homo sapiens_hsa00071 | 1.22756061 |
| 33 | cGMP-PKG signaling pathway_Homo sapiens_hsa04022 | 1.20555374 |
| 34 | Valine, leucine and isoleucine degradation_Homo sapiens_hsa00280 | 1.13412162 |
| 35 | Arginine and proline metabolism_Homo sapiens_hsa00330 | 1.13342506 |
| 36 | Focal adhesion_Homo sapiens_hsa04510 | 1.10835536 |
| 37 | Vascular smooth muscle contraction_Homo sapiens_hsa04270 | 1.08236629 |
| 38 | Pentose phosphate pathway_Homo sapiens_hsa00030 | 1.05652713 |
| 39 | GnRH signaling pathway_Homo sapiens_hsa04912 | 1.04271267 |
| 40 | Alanine, aspartate and glutamate metabolism_Homo sapiens_hsa00250 | 1.04025481 |
| 41 | FoxO signaling pathway_Homo sapiens_hsa04068 | 1.03694822 |
| 42 | Central carbon metabolism in cancer_Homo sapiens_hsa05230 | 1.00742058 |
| 43 | Gastric acid secretion_Homo sapiens_hsa04971 | 0.99237017 |
| 44 | Longevity regulating pathway - mammal_Homo sapiens_hsa04211 | 0.93379027 |
| 45 | Glyoxylate and dicarboxylate metabolism_Homo sapiens_hsa00630 | 0.93342406 |
| 46 | Arginine biosynthesis_Homo sapiens_hsa00220 | 0.93140139 |
| 47 | Oxidative phosphorylation_Homo sapiens_hsa00190 | 0.90429199 |
| 48 | mTOR signaling pathway_Homo sapiens_hsa04150 | 0.89142405 |
| 49 | VEGF signaling pathway_Homo sapiens_hsa04370 | 0.81151092 |
| 50 | Fatty acid metabolism_Homo sapiens_hsa01212 | 0.80426380 |
| 51 | MAPK signaling pathway_Homo sapiens_hsa04010 | 0.79014734 |
| 52 | HIF-1 signaling pathway_Homo sapiens_hsa04066 | 0.78746829 |
| 53 | Glycine, serine and threonine metabolism_Homo sapiens_hsa00260 | 0.70334495 |
| 54 | Renin secretion_Homo sapiens_hsa04924 | 0.67336323 |
| 55 | Platelet activation_Homo sapiens_hsa04611 | 0.62657681 |
| 56 | Type II diabetes mellitus_Homo sapiens_hsa04930 | 0.56189996 |
| 57 | Insulin secretion_Homo sapiens_hsa04911 | 0.55132496 |
| 58 | Proteoglycans in cancer_Homo sapiens_hsa05205 | 0.54550630 |
| 59 | Leukocyte transendothelial migration_Homo sapiens_hsa04670 | 0.52587424 |
| 60 | Regulation of actin cytoskeleton_Homo sapiens_hsa04810 | 0.51122189 |
| 61 | Fatty acid biosynthesis_Homo sapiens_hsa00061 | 0.48004361 |
| 62 | Amoebiasis_Homo sapiens_hsa05146 | 0.46134771 |
| 63 | PPAR signaling pathway_Homo sapiens_hsa03320 | 0.45459405 |
| 64 | Terpenoid backbone biosynthesis_Homo sapiens_hsa00900 | 0.43923722 |
| 65 | Fc epsilon RI signaling pathway_Homo sapiens_hsa04664 | 0.43793007 |
| 66 | Other glycan degradation_Homo sapiens_hsa00511 | 0.43359594 |
| 67 | Renal cell carcinoma_Homo sapiens_hsa05211 | 0.43156427 |
| 68 | Aldosterone synthesis and secretion_Homo sapiens_hsa04925 | 0.41101805 |
| 69 | Adherens junction_Homo sapiens_hsa04520 | 0.40624249 |
| 70 | Salivary secretion_Homo sapiens_hsa04970 | 0.35664401 |
| 71 | Glycosphingolipid biosynthesis - ganglio series_Homo sapiens_hsa00604 | 0.33310731 |
| 72 | Regulation of autophagy_Homo sapiens_hsa04140 | 0.32991125 |
| 73 | Long-term depression_Homo sapiens_hsa04730 | 0.32922348 |
| 74 | Huntingtons disease_Homo sapiens_hsa05016 | 0.32200587 |
| 75 | Cholinergic synapse_Homo sapiens_hsa04725 | 0.31368083 |
| 76 | Endocrine and other factor-regulated calcium reabsorption_Homo sapiens_hsa04961 | 0.29791316 |
| 77 | AGE-RAGE signaling pathway in diabetic complications_Homo sapiens_hsa04933 | 0.28824268 |
| 78 | beta-Alanine metabolism_Homo sapiens_hsa00410 | 0.28675848 |
| 79 | Proximal tubule bicarbonate reclamation_Homo sapiens_hsa04964 | 0.28445963 |
| 80 | Regulation of lipolysis in adipocytes_Homo sapiens_hsa04923 | 0.27611707 |
| 81 | Osteoclast differentiation_Homo sapiens_hsa04380 | 0.27253763 |
| 82 | Neurotrophin signaling pathway_Homo sapiens_hsa04722 | 0.26212521 |
| 83 | Prolactin signaling pathway_Homo sapiens_hsa04917 | 0.24321692 |
| 84 | Bladder cancer_Homo sapiens_hsa05219 | 0.23268605 |
| 85 | Butanoate metabolism_Homo sapiens_hsa00650 | 0.21313256 |
| 86 | Tuberculosis_Homo sapiens_hsa05152 | 0.21284735 |
| 87 | Circadian entrainment_Homo sapiens_hsa04713 | 0.20658986 |
| 88 | Chronic myeloid leukemia_Homo sapiens_hsa05220 | 0.20216572 |
| 89 | Pertussis_Homo sapiens_hsa05133 | 0.19949894 |
| 90 | Acute myeloid leukemia_Homo sapiens_hsa05221 | 0.19551385 |
| 91 | Long-term potentiation_Homo sapiens_hsa04720 | 0.19220919 |
| 92 | Inflammatory mediator regulation of TRP channels_Homo sapiens_hsa04750 | 0.18382882 |
| 93 | Toll-like receptor signaling pathway_Homo sapiens_hsa04620 | 0.17869160 |
| 94 | Peroxisome_Homo sapiens_hsa04146 | 0.17783780 |
| 95 | Tryptophan metabolism_Homo sapiens_hsa00380 | 0.17372099 |
| 96 | Nitrogen metabolism_Homo sapiens_hsa00910 | 0.16253811 |
| 97 | T cell receptor signaling pathway_Homo sapiens_hsa04660 | 0.15417788 |
| 98 | cAMP signaling pathway_Homo sapiens_hsa04024 | 0.15377333 |
| 99 | Glioma_Homo sapiens_hsa05214 | 0.13246158 |
| 100 | Melanogenesis_Homo sapiens_hsa04916 | 0.11901979 |
| 101 | Sulfur relay system_Homo sapiens_hsa04122 | 0.11202253 |
| 102 | Bile secretion_Homo sapiens_hsa04976 | 0.10290535 |
| 103 | Amyotrophic lateral sclerosis (ALS)_Homo sapiens_hsa05014 | 0.09691446 |
| 104 | Carbohydrate digestion and absorption_Homo sapiens_hsa04973 | 0.09530053 |
| 105 | Pancreatic secretion_Homo sapiens_hsa04972 | 0.08226714 |
| 106 | Phenylalanine metabolism_Homo sapiens_hsa00360 | 0.07790628 |
| 107 | B cell receptor signaling pathway_Homo sapiens_hsa04662 | 0.06426276 |
| 108 | Non-small cell lung cancer_Homo sapiens_hsa05223 | 0.06380895 |
| 109 | Signaling pathways regulating pluripotency of stem cells_Homo sapiens_hsa04550 | 0.05957262 |
| 110 | Lysine degradation_Homo sapiens_hsa00310 | 0.05709933 |
| 111 | Leishmaniasis_Homo sapiens_hsa05140 | 0.05322582 |
| 112 | Thyroid hormone signaling pathway_Homo sapiens_hsa04919 | 0.04293973 |
| 113 | ErbB signaling pathway_Homo sapiens_hsa04012 | 0.04229564 |
| 114 | Olfactory transduction_Homo sapiens_hsa04740 | 0.03745488 |
| 115 | Glycerophospholipid metabolism_Homo sapiens_hsa00564 | 0.03694140 |
| 116 | Gap junction_Homo sapiens_hsa04540 | 0.03427639 |

